Literature DB >> 11873866

A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome.

A Ohashi1, Y Yamada, K Sakaguchi, T Inoue, M Kubo, H Fushimi.   

Abstract

A 49-year-old man was referred to our hospital for the treatment of gallstones in 1993. Bilateral adrenal nodular masses were detected incidentally by abdominal computed tomography. He had no clinical signs of Cushing's syndrome such as central obesity, striae of skin and diabetes mellitus. We performed cholecystectomy and partial adrenalectomy of right adrenal gland as a biopsy, and diagnosed him as preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) based on endocrinological and histological examinations. We followed him up for 7 years. During the observation period, the sizes of both adrenal glands increased gradually, and finally serum cortisol level increased beyond normal range, and he showed a Cushingoid appearance such as moon face and central obesity. His skin became atrophic and very fragile, and the bone mineral density of his lumbar spine was extremely low. Serum cortisol level was elevated, and plasma ACTH level was always suppressed. Urinary excretion of 17-hydroxycorticosteroid and free cortisol were increased. Diurnal rhythm of cortisol and ACTH was completely lost and high dose (8 mg/day) dexamethasone did not suppress urinary 17-hydroxycorticosteroid excretion. He became clinically overt Cushing's syndrome. We recommended total adrenalectomy, but he refused it. It is important to know the natural history of preclinical Cushing's syndrome due to AIMAH when choosing an adequate treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11873866     DOI: 10.1507/endocrj.48.677

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

1.  The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH).

Authors:  Maurizio Iacobone; Nora Albiger; Carla Scaroni; Franco Mantero; Ambrogio Fassina; Giovanni Viel; Mauro Frego; Gennaro Favia
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

2.  Classification, diagnosis and treatment of ACTH-independent macronodular adrenal hyperplasia.

Authors:  Heng-Chuan Su; Jun Dai; Xin Huang; Wen-Long Zhou; Bao-Xing Huang; Wan-Li Cao; Fu-Kang Sun
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

Review 3.  Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review.

Authors:  Vajihe Chavoshi; Seyed Saeed Tamehri Zadeh; Shayesteh Khalili; Amirhassan Rabbani; Seyed Amir Hassan Matini; Zhaleh Mohsenifar; Farzad Hadaegh
Journal:  BMC Endocr Disord       Date:  2022-04-21       Impact factor: 3.263

4.  ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers.

Authors:  Chika Kyo; Takeshi Usui; Rieko Kosugi; Mizuki Torii; Takako Yonemoto; Tatsuo Ogawa; Masato Kotani; Naohisa Tamura; Yutaro Yamamoto; Takuyuki Katabami; Isao Kurihara; Kohei Saito; Naotetsu Kanamoto; Hidenori Fukuoka; Norio Wada; Hiroyuki Murabe; Tatsuhide Inoue
Journal:  J Endocr Soc       Date:  2019-07-23

5.  ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.

Authors:  Liping Yu; Junqing Zhang; Xiaohui Guo; Xiaoyu Chen; Zhisong He; Qun He
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.